WEE1 and ovarian carcinoma: Notably, PIK3CA activated mutation participates in the PI3K pathway which is activated in approximately 70% of ovarian cancer [49], and is enriched in regulation of protein kinase B signaling, which is activated by autocrine or paracrine signaling through protein kinase signaling in many kinds of cancers [49].